Tyra Biosciences, Inc. (TYRA) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Tyra Biosciences, Inc. (TYRA) quarterly cash flow statement — complete operating, investing & financing history

Quarterly statement

TYRA Cash Flow Statement

Tyra Biosciences, Inc. (TYRA) cash flow statement — 7-year operating, investing & financing cash flows

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Cash from Operations	-31.08M	-32.57M	-23.62M	-22.38M	-23.68M	-25.46M	-19.59M	-17.9M	-10.26M	-22.03M	-13.53M	-17.14M	-9.62M	-9.85M	-11.98M	-12.21M	-17.17M	-8.93M	-9.03M	-5.58M
Operating CF Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating CF Growth %	-31.23%	-27.94%	-20.59%	-25.04%	-130.84%	-15.57%	-44.77%	-4.39%	-6.69%	-123.7%	-12.95%	-40.39%	43.99%	-10.33%	-32.7%	-118.93%	-284.85%	-90.79%	-256.84%	-
Net Income	-45.56M	-39.3M	-33.83M	-29.87M	-28.1M	-28.15M	-25.57M	-24.02M	-18.7M	-18.19M	-22.83M	-21.15M	-13.27M	-11.88M	-12.89M	-12.51M	-15.1M	-14.83M	-9.93M	-6.64M
Depreciation & Amortization	138K	138K	132K	131K	140K	143K	144K	127K	126K	122K	102K	82K	86K	83K	82K	82K	68K	64K	50K	41K
Stock-Based Compensation	10.23M	7.85M	7.63M	7.58M	6.38M	6.42M	6.7M	7.57M	4.41M	4.12M	4.19M	0	0	2.43M	2.91M	1.02M	2.69M	3.97M	1.87M	507K
Deferred Taxes	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	483K	0
Other Non-Cash Items	-145K	-65K	-126K	-419K	-708K	-866K	-1.18M	-1.6M	-1.87M	-1.23M	-1.25M	4.38M	2.53M	0	0	1K	0	2K	-483K	3K
Working Capital Changes	4.26M	-1.19M	2.58M	199K	-1.39M	-3.01M	318K	23K	5.77M	-6.84M	6.26M	-453K	1.04M	-483K	-2.08M	-805K	-4.83M	1.86M	-1.02M	514K
Change in Receivables	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in Inventory	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in Payables	5.32M	1.2M	0	0	0	0	0	0	0	0	0	0	0	0	207K	48K	542K	1.56M	96K	1.23M
Cash from Investing	17.85M	-120.24M	34.38M	-14.81M	20.87M	32.03M	6.96M	21.56M	-144.99M	18.07M	-144.44M	-83K	-43K	-41K	-21K	-48K	-251K	-239K	-105K	-240K
Capital Expenditures	-66K	-88K	-57K	-39K	-31K	-14K	-6K	-52K	-470K	-136K	-603K	-83K	-43K	-41K	-21K	-48K	-251K	-239K	-105K	-256K
CapEx % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Acquisitions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Investing	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16K
Cash from Financing	2.1M	160.38M	4.68M	647K	583K	2.19M	706K	743K	373K	200.31M	324K	467K	370K	376K	3K	364K	27K	238K	-1.51M	183.44M
Debt Issued (Net)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Equity Issued (Net)	2.1M	160.38M	4.68M	647K	583K	2.19M	706K	743K	-251K	199.83M	324K	467K	370K	376K	-629K	364K	27K	238K	-1.51M	-23K
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Share Repurchases	0	0	0	0	0	0	0	0	-251K	-169K	0	0	0	0	0	0	0	0	0	0
Other Financing	0	0	0	0	0	0	0	0	624K	484K	0	0	0	0	632K	0	0	0	0	183.46M
Net Change in Cash	-11.12M	7.57M	15.44M	-36.54M	-2.23M	8.76M	-11.93M	4.4M	-154.88M	196.36M	-157.65M	-16.76M	-9.29M	-9.51M	-12M	-11.9M	-17.39M	-8.93M	-10.64M	177.62M
Free Cash Flow	-31.14M	-32.66M	-23.68M	-22.42M	-23.71M	-25.47M	-19.6M	-17.95M	-10.73M	-22.16M	-14.13M	-17.23M	-9.66M	-9.89M	-12M	-12.26M	-17.42M	-9.16M	-9.13M	-5.83M
FCF Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FCF Growth %	-31.34%	-28.22%	-20.85%	-24.9%	-121.02%	-14.93%	-38.63%	-4.19%	-11.08%	-124.15%	-17.78%	-40.52%	44.55%	-7.9%	-31.4%	-110.15%	-270.54%	-93.41%	-251.68%	-
FCF per Share	-0.47	-0.53	-0.40	-0.38	-0.40	-0.43	-0.33	-0.30	-0.18	-0.42	-0.33	-0.40	-0.23	-0.23	-0.28	-0.29	-0.42	-0.22	-0.22	-0.64
FCF Conversion (FCF/Net Income)	0.68x	0.83x	0.70x	0.75x	0.84x	0.90x	0.77x	0.75x	0.55x	1.21x	0.59x	0.81x	0.72x	0.83x	0.93x	0.98x	1.14x	0.60x	0.91x	0.84x
Interest Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Taxes Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0